Results 331 to 340 of about 5,215,493 (360)

Preclinical Characterization of SDFZ-8, a Highly Potent HDAC1 Inhibitor, for Cancer Immunotherapy. [PDF]

MedComm (2020)
Zhou Y, Du J, Li X, Zhao H, Xue J, Liu Y, Yang X, Yu J, Hou X, Fang H.   +9 more
europepmc   +1 more source

Nanodelivery Strategies for STING Agonists: Toward Efficient Cancer Immunotherapy. [PDF]

Int J Nanomedicine
Zhang M, Ji Y, Liu M, Liu Y, Tong S, Cai Y, Liu M, Qu N.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Advances in cancer immunotherapy: historical perspectives, current developments, and future directions

Molecular Cancer
Cancer immunotherapy, encompassing both experimental and standard-of-care therapies, has emerged as a promising approach to harnessing the immune system for tumor suppression.
Meiyin Zhang, Chaojun Liu, Jing Tu, Min Tang, M. Ashrafizadeh, Noushin Nabavi, Gautam Sethi, Peiqing Zhao, Shijian Liu   +8 more
semanticscholar   +1 more source

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges

Molecular Cancer
Clinically, multimodal therapies are adopted worldwide for the management of cancer, which continues to be a leading cause of death. In recent years, immunotherapy has firmly established itself as a new paradigm in cancer care that activates the body’s ...
Man Wang, Fei Yu, Yuan Zhang
semanticscholar   +1 more source

Corticosteroids and Cancer Immunotherapy.

Clinical Cancer Research, 2023
Despite revolutionizing cancer management, immunotherapies dysregulate the immune system leading to immune-mediated adverse events. These common and potentially dangerous toxicities are often treated with corticosteroids, which are among the most ...
Rachel S Goodman, Douglas B. Johnson, J. Balko   +2 more
semanticscholar   +1 more source

Resistance Mechanisms to Anti-PD Cancer Immunotherapy.

Annual Review of Immunology, 2022
The transformative success of antibodies targeting the PD-1 (programmed death 1)/B7-H1 (B7 homolog 1) pathway (anti-PD therapy) has revolutionized cancer treatment.
M. Vesely, Tianxiang Zhang, Lieping Chen
semanticscholar   +1 more source

Dynamics and specificities of T cells in cancer immunotherapy

Nature Reviews. Cancer, 2023
G. Oliveira, Catherine J. Wu
semanticscholar   +1 more source

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

The emerging roles of γδ T cells in cancer immunotherapy

Nature Reviews Clinical Oncology, 2023
Sofia Mensurado, Rafael Blanco-Domínguez, B. Silva‐Santos   +2 more
semanticscholar   +1 more source

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly